anmelden
SLI
2.143,87
PKT
+4,47
PKT
+0,21
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.01.18 | Givaudan overweight | JP Morgan Chase & Co. | |
| 10.01.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 10.01.18 | UBS Hold | Société Générale Group S.A. (SG) | |
| 10.01.18 | Holcim Hold | Deutsche Bank AG | |
| 10.01.18 | UBS Hold | Société Générale Group S.A. (SG) | |
| 09.01.18 | ABB (Asea Brown Boveri) Hold | Société Générale Group S.A. (SG) | |
| 09.01.18 | ABB (Asea Brown Boveri) Neutral | Merrill Lynch & Co., Inc. | |
| 08.01.18 | Holcim Outperform | Bernstein Research | |
| 08.01.18 | Givaudan Underperform | Bernstein Research | |
| 08.01.18 | Roche Neutral | UBS AG | |
| 08.01.18 | Givaudan Underperform | Bernstein Research | |
| 05.01.18 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 05.01.18 | Swiss Re buy | Deutsche Bank AG | |
| 05.01.18 | Zurich Insurance Hold | Kepler Cheuvreux | |
| 05.01.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.01.18 | UBS Sector Perform | RBC Capital Markets | |
| 05.01.18 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 05.01.18 | Swiss Re Sell | UBS AG | |
| 05.01.18 | Roche buy | Jefferies & Company Inc. | |
| 04.01.18 | UBS buy | UBS AG | |
| 04.01.18 | Swiss Re buy | Deutsche Bank AG | |
| 04.01.18 | Zurich Insurance Hold | Deutsche Bank AG | |
| 03.01.18 | Givaudan overweight | JP Morgan Chase & Co. | |
| 03.01.18 | Nestlé overweight | JP Morgan Chase & Co. | |
| 03.01.18 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 03.01.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 29.12.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 29.12.17 | Roche overweight | JP Morgan Chase & Co. | |
| 29.12.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 27.12.17 | Novartis Halten | Norddeutsche Landesbank (Nord/LB) | |
| 27.12.17 | Roche kaufen | Norddeutsche Landesbank (Nord/LB) | |
| 21.12.17 | Roche overweight | Barclays Capital | |
| 20.12.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.12.17 | UBS Sector Perform | RBC Capital Markets | |
| 18.12.17 | UBS Outperform | RBC Capital Markets | |
| 18.12.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 14.12.17 | ABB (Asea Brown Boveri) kaufen | Kepler Cheuvreux | |
| 14.12.17 | Zurich Insurance Reduce | Commerzbank AG | |
| 14.12.17 | Holcim Neutral | JP Morgan Chase & Co. | |
| 13.12.17 | Zurich Insurance Neutral | Macquarie Research |